Form 4: Encompass Health Director Acquires Shares Through Dividend Reinvestment and Deferred Compensation Plan

Director Edward M. Christie III increased his holdings in Encompass Health through dividend reinvestment and a deferred stock investment plan.

Summary

• Director Edward M. Christie III acquired additional shares of Encompass Health stock through two transactions.
• The first transaction involved the acquisition of 6 shares of common stock on January 15, 2025, resulting from a dividend reinvestment program.
• The second transaction involved the acquisition of 292 shares of common stock on January 16, 2025, through the company's Directors Deferred Stock Investment Plan.
• The shares acquired through the deferred plan were purchased at a weighted average price of $94.40 per share, with individual transactions ranging from $94.35 to $94.41.
• The dividend paid on January 15, 2025, was $0.17 per share, and the closing price of the stock on that day was $93.61.

Sentiment

Score: 7

Explanation: The document reflects a positive sentiment as it shows a director increasing their stake in the company through standard compensation and dividend reinvestment programs, indicating confidence in the company's future.

Positives

• The director's participation in the deferred stock investment plan demonstrates confidence in the company's future.
• Dividend reinvestment further aligns the director's interests with those of shareholders.

Industry Context

This filing is a routine disclosure of a director's stock transactions and is typical for publicly traded companies. It reflects standard practices for director compensation and alignment with shareholder interests.

Comparison to Industry Standards

• Director stock ownership and deferred compensation plans are common practices among publicly traded companies, including those in the healthcare sector such as Select Medical Holdings Corporation (SEM) and HCA Healthcare (HCA).
• These plans are designed to align the interests of directors with those of shareholders by incentivizing long-term value creation.
• The dividend reinvestment program is also a standard practice, allowing directors to increase their stake in the company without additional cash outlay.

Stakeholder Impact

• The transactions have a minor positive impact on shareholders as they demonstrate director confidence in the company.
• The transactions have no direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Encompass Health, Director, Stock Acquisition, Dividend Reinvestment, Deferred Stock Plan, EHC, Form 4